A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

334

HTML

2813

Figures (1-2)

128

Tables (1-6)

120

Sum=3395

Jan 7, 2008 (publication date) through Apr 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jan 7, 2008; 14(1): 114-119
Published online Jan 7, 2008. doi: 10.3748/wjg.14.114

Figure 1 Mayo scores of TG and CG at initial and final points.

Figure 2 The clinical remission rate of TG vs CG.

Citation: Liang HL, Ouyang Q. A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. World J Gastroenterol 2008; 14(1): 114-119
URL: https://www.wjgnet.com/1007-9327/full/v14/i1/114.htm
DOI: https://dx.doi.org/10.3748/wjg.14.114